磁共振引导聚焦超声囊切开术治疗难治性强迫症与重性抑郁障碍的I期试验临床与影像结果
两项I期试验评估磁共振引导聚焦超声双侧前囊切开术治疗难治性强迫症(N=6)和重性抑郁障碍(N=6)的安全性、临床反应与影像学关联。无严重不良事件,非严重不良事件为头痛和针位肿胀(7/12);强迫症组反应率4/6,抑郁组2/6。弥散MRI结构连接组显示受影响白质束主要终止于额极、内侧丘脑、纹状体和内侧颞叶;PET(9例)显示治疗后6个月双侧大脑半球代谢广泛降低,右侧海马、杏仁核和壳核亦降低;治疗前静息态fMRI(12例)发现三个体素簇与最终临床反应显著相关。
要点
- MRgFUS双侧前囊切开术在难治性强迫症和抑郁障碍中无严重不良事件,非严重不良事件为头痛和针位肿胀(7/12)。
- 强迫症组反应率4/6,抑郁障碍组2/6。
- 治疗后6个月PET显示双侧大脑半球及右侧海马、杏仁核、壳核代谢广泛降低。
核心结论
- MRgFUS囊切开术看似安全、耐受良好,初步结果提示可能为难治性强迫症和重性抑郁障碍的重要治疗选择。
- MRgFUS囊切开术导致靶向及广泛的神经活动改变,神经影像可能有助于预测结局。
研究设计与样本
- 两项I期试验,纳入难治性强迫症患者6例和重性抑郁障碍患者6例,评估MRgFUS双侧前囊切开术的安全性、临床反应和影像学关联。
主要发现
- 无严重不良事件;非严重不良事件包括头痛和针位肿胀,发生于7/12例患者。
- 强迫症组反应率为4/6,重性抑郁障碍组为2/6。
- 基于 normative 弥散MRI的结构连接组显示,受囊切开术影响的白质束主要终止于额极、内侧丘脑、纹状体和内侧颞叶。
- PET分析(9例)显示治疗后6个月双侧大脑半球代谢广泛降低,右侧海马、杏仁核和壳核代谢亦降低。
- 治疗前 seed-to-voxel 静息态fMRI分析(12例)发现三个体素簇与最终临床反应显著相关。
临床怎么用
- 对于难治性强迫症和重性抑郁障碍,MRgFUS前囊切开术可作为潜在治疗选择,需关注头痛和针位肿胀等非严重不良事件。
- 神经影像(结构连接组、PET、静息态fMRI)可用于理解手术靶点与反应预测,但尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obsessive compulsive disorder (OCD) and major depressive disorder (MDD) are common, often refractory, neuropsychiatric conditions for which new treatment approaches are urgently needed. Magnetic resonance-guided focused ultrasound (MRgFUS) is a novel surgical technique permitting incisionless ablative neurosurgery. We examined the safety profile, clinical response, and imaging correlates of MRgFUS bilateral anterior capsulotomy in patients with refractory obsessive compulsive disorder (OCD, N = 6) and major depressive disorder (MDD, n = 6). There were no serious adverse events. Nonserious adverse events included headaches and pin-site swelling in 7/12 patients. The response rate was 4/6 and 2/6 in the OCD and MDD cohorts respectively. To delineate the white-matter tracts impacted by capsulotomy, a normative diffusion MRI-based structural connectome was used, revealing tracts terminating primarily in the frontal pole, medial thalamus, striatum, and medial-temporal lobe. Positron emission tomography (PET) analysis (nine subjects) revealed widespread decreases in metabolism bilaterally in the cerebral hemispheres at 6 months post treatment, as well as in the right hippocampus, amygdala, and putamen. A pretreatment seed-to-voxel resting-state functional magnetic resonance imaging (rs-fMRI) analysis (12 subjects) revealed three voxel clusters significantly associated with eventual clinical response. MRgFUS capsulotomy appears to be safe, well tolerated, and according to these initial results, may be an important treatment option for patients with refractory OCD and MDD. MRgFUS capsulotomy results in both targeted and widespread changes in neural activity, and neuroimaging may hold potential for the prediction of outcome.
引用
- Davidson B, Hamani C, Rabin JS, et al. Magnetic resonance-guided focused ultrasound capsulotomy for refractory obsessive compulsive disorder and major depressive disorder: clinical and imaging results from two phase I trials. Mol Psychiatry. 2020. PMID: 32404942. doi:10.1038/s41380-020-0737-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。